Related by context. All words. (Click for frequent words.) 73 Neo Kidney Augment 68 Zemiva TM 68 Iluvien ® 68 PrevOnco ™ 67 targeted radiotherapeutic 67 PDX pralatrexate 67 Zemiva ™ 67 sumatriptan DosePro 67 molecular imaging radiopharmaceutical 67 topically applied SEPA 67 BiovaxID TM 67 Generx TM 67 Personalized Immunotherapy 67 Azedra ™ 67 Augment TM 67 MOZOBIL 67 Polymer Microspheres 66 delivers fluocinolone acetonide FA 66 candidate deforolimus 66 Nektar proprietary 66 Solazed TM 66 polysaccharide polymer 66 IRX 2 66 IMA# 66 Tengion Neo Urinary Conduit 66 Onalta ™ 66 Perflubutane Polymer Microspheres 66 Anturol ® 66 investigational pharmacologically unique 66 CB2 selective receptor agonist 65 anticancer compound 65 Celacade TM technology 65 BHT DNA 65 modified glutathione analog 65 OMS#HP 65 Cintredekin Besudotox 65 Generx ™ 65 PNP inhibitor 65 investigational pan BCR 65 candidate TNFerade biologic 65 Azedra TM 65 QuadraSphere 65 bucindolol hydrochloride 65 Omigard 64 Allovectin 7 R 64 AzaSite Xtra 64 Panzem R 64 PrevOnco 64 novel L DOS# 64 Chrysalin 64 Veronate 64 Neovasc Reducer 64 candidate ridaforolimus 64 Azedra TM Onalta TM 64 candidate REP# 64 Angiocept 64 Altropane 64 TOCOSOL Paclitaxel 64 Phase #b/#a clinical 64 PLK1 SNALP 64 mertansine 64 GLP1 INT TM 64 Surfaxin LS 64 concerning CombinatoRx 64 systemic immunosuppressive drugs 64 proprietary HuCNS SC 64 Bone Graft 64 targets Galectin receptors 64 RH1 targeted chemotherapeutic agent 64 oral prodrug 64 Myocet 64 Intermezzo ® zolpidem tartrate 63 phase IIb clinical 63 HeartMate ® 63 candidate Gencaro TM 63 Duromist ™ 63 MAXY G# 63 sodium Injection 63 candidate EFAPROXYN TM 63 Excellarate TM 63 investigational humanized monoclonal antibody 63 KNS # 63 include PLX IBD 63 Organ Regeneration Platform 63 CEQ# 63 Tarmogen 63 SEPET TM 63 Oral NKTR 63 Xcytrin R 63 Factor VIIa 63 Cinryze TM C1 inhibitor 63 candidate Ramoplanin 63 Powerlink ® 63 oxybutynin ATD TM 63 Stedivaze 63 individualized cellular immunotherapy 63 XL# anticancer compounds 63 Locteron ® 63 Trofex 63 Cleviprex TM clevidipine 63 Archexin 63 JZP 63 XL# XL# XL# 63 APC Targeting Technology 63 FOLOTYN ® 63 TRO# 63 OncoGel 63 Genasense ® oblimersen 63 DOS# 63 XL# XL# XL# XL# 63 overactive bladder AA# 63 Solazed ™ 63 Cannabinor 63 SPL# Gel vaginal microbicide 63 TOCOSOL Camptothecin 62 TAXUS TM 62 ALN PCS 62 targeting Inflammatory Bowel 62 tiapamil 62 PDE4 inhibitor 62 HuMax CD#b 62 DPX Survivac 62 Phase Ib clinical trials 62 Chemophase 62 ocular formulation 62 Memryte 62 KRYSTEXXA TM pegloticase 62 active cellular immunotherapy 62 personalized cellular immunotherapy 62 OMNARIS Nasal Spray 62 TELINTRA 62 XP# XP# 62 product platforms AZX# 62 TBC# 62 Dyloject TM 62 oxybutynin ATD ™ 62 StemEx R 62 Troxatyl 62 OvaRex R 62 Cotavance 62 Augment ™ 62 dacetuzumab SGN 62 Aganocide 62 M Enoxaparin 62 ELADUR 62 Bioral Amphotericin B. 62 Synavive ™ 62 Azedra 62 EVIZON TM squalamine lactate 62 Acetavance TM intravenous acetaminophen 62 HQK 62 candidate NGX 62 VIAdel TM technology 62 therapeutic monoclonal antibody 62 oncolytic virus therapies 62 generation rotary VAD 62 BrachySil 62 EP #R 62 Aurexis 62 Kuvan TM sapropterin 62 IMPDH inhibitor 62 Harbor BioSciences 62 Auxilium transmucosal film 62 IL# PE#QQR 62 Levacor VAD 62 THR beta agonist 62 PANVAC VF 62 ATS CryoMaze TM 62 LungExpress Dx TM 62 BioSTAR ® 62 orBec ® oral beclomethasone 62 HuMax TAC 62 DuraHeart 62 Alzhemed TM 62 candidate AP# 62 PROVENGE sipuleucel T 61 percutaneous aortic valve 61 LE SN# 61 Neo Kidney Augment ™ 61 VALSTAR 61 Sopherion 61 tivozanib 61 Solazed 61 MKC# MKC# PP 61 Adhesion Barrier 61 vernakalant oral 61 Proxinium TM 61 Phase III Pivotal 61 Zelrix 61 Excellagen 61 HuCNS SC ® 61 bioartificial liver device 61 pralatrexate 61 TKM ApoB 61 PREOS R 61 prostate cancer antigen prostatic 61 phase IIa clinical 61 oral picoplatin 61 Cardium Therapeutics TM 61 Anturol 61 Cardio Vascu Grow 61 REG2 Regado 61 WavSTAT 61 candidates Augment ™ 61 S1P antibody 61 MYDICAR 61 virus HCV protease inhibitor 61 VIAtab TM 61 R#/MEM # 61 TRANSDUR Sufentanil 61 Exelixis compounds 61 Chemokine Therapeutics 61 Depomed formulates 61 PORxin TM 61 Aerosurf 61 Soliris TM eculizumab 61 Topical Interferon Alpha 2b 61 omecamtiv mecarbil formerly 61 Genasense R oblimersen 61 faropenem medoxomil 61 candidate AQ4N 61 ApoB SNALP 61 XL# XL# 61 accumulate preferentially 61 Loramyc TM 61 Cloretazine ® 61 ALN TTR# 61 motexafin gadolinium Injection 61 sapropterin dihydrochloride Phase 61 Ferumoxytol 61 drug ISA# 61 Besivance 61 BrachySil TM 61 LEUKINE 61 selective androgen receptor modulator 61 Curaxin CBLC# 61 Iluvien TM 61 FACTIVE R gemifloxacin 61 Kosan dependence 61 orBec R oral beclomethasone 61 Optiquel ™ 61 AzaSite Plus 61 Zemiva TM Trofex TM 61 ALTROPANE R 61 Civacir 61 thrombin component 61 Biliary System 61 TLK# 61 JAK1 61 lead molecular radiotherapeutic 61 PEG SN# 61 chemosaturation 61 hypoxia activated prodrug 61 selective immunoproteasome inhibitor 61 Androxal TM 61 Relivar 61 candidate Zenvia 61 M# rationally 61 targeted antifolate 61 proprietary transdermal 61 candidate Zemiva 61 HDL Selective Delipidation 61 proprietary Isolagen Process 61 rALLy clinical trial 61 SinuNase TM 60 proprietary transdermal patch 60 Phase Ib study 60 MyVax R 60 TRIOLEX HE# APOPTONE HE# 60 IntuiTrak 60 GED aPC 60 Nanobody R 60 Genitope Corporation 60 ABL inhibitor 60 Ophena 60 CCX# 60 PresbyLens ® 60 Nanobody 60 lucinactant 60 Fodosine 60 registrational 60 LEP ETU 60 MelaFind R 60 LVAS 60 PHX# 60 Eluting Coronary Stent System 60 Nventa proprietary CoVal 60 Empatic ™ 60 VITOSS 60 RIGScan CR 60 candidate HuCNS SC 60 PRECISE trial 60 RECOTHROM R 60 drug pipeline TAFA# 60 orally administered inhibitor 60 rNAPc2 60 allosteric modulator 60 FUSILEV ® 60 Vascular Wrap TM 60 aldehyde dehydrogenase ALDH2 deficiency 60 rusalatide acetate 60 confirmatory Phase III 60 candidate brentuximab vedotin 60 investigational antiplatelet agent 60 NeuroSTAT ® 60 Shigamabs R 60 ONCONASE R 60 Initiate Clinical Trial 60 seliciclib CYC# 60 bardoxolone 60 MOVIPREP R 60 GEM OS2 60 LibiGel ® 60 candidates bavituximab 60 RNAi compounds rxRNA 60 HeartMate R 60 NexACT ® 60 urethral bulking agent 60 Ventricular Assist System 60 Ketotransdel 60 SinuNase ™ 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 BioSTAR R 60 TOCOSOL 60 Loramyc R 60 REPEL CV 60 dihydrochloride Phase 3 60 include Phenoptin TM 60 theranostic 60 Hematide TM 60 immunotherapies 2A/Furin 60 reslizumab 60 huC# DM4 60 SinuNase TM novel 60 OvaRex ® MAb 60 non porcine pancreatic 60 Allovectin 7 r 60 Durata 60 Fx #A 60 MYDICAR ® 60 immatics 60 PEGylation technology 60 platinum chemotherapeutic 60 topical anti infective 60 HepeX B 60 LightTouch 60 HEPLISAV TM 60 signal detection CTSD 60 Tissue Matrix 60 Alfacell proprietary ribonuclease 60 KL4 Surfactant 60 Levacor 60 ORE# 60 Soliris eculizumab 60 Anturol TM 60 Cardica Microcutter XPRESS 60 ILUVIEN ® 60 TELCYTA 60 DAVANAT R 60 lintuzumab SGN 60 IND submission 60 Entereg TM 60 Augment Injectable 60 TRIOLEX HE# 60 HepeX B TM 60 BioSTAR TM 60 TYZEKA 60 IoGen 60 cangrelor 60 patented Bioral 60 ELADUR TM 60 CRMD# 60 HCV protease inhibitor 60 Phase 2a clinical 60 product ColonSentry TM 59 HDL Mimetic Peptide 59 Alnylam #x# 59 granted Ortec 59 mitogen activated ERK kinase 59 Aganocide ® 59 pipeline GlycoPEG GCSF 59 Anticalin R 59 treat male hypogonadism 59 Prednisporin 59 potentially treat nephropathic 59 dermaPACE TM 59 torezolid phosphate 59 RhuDex ® 59 GVAX R 59 PROVENGE ® 59 HepaMate 59 CoFactor 59 VitiGam 59 Picoplatin 59 EFAPROXYN 59 TRANSDUR ™ 59 JOULFERON 59 Fleximer 59 Alocrest 59 CCG TH# 59 acetonide FA 59 Bezielle 59 ruxolitinib 59 TRANSDUR ® 59 Investigational Device Exemption IDE 59 dextofisopam 59 ALN VSP 59 eTag assays 59 StemEx 59 Xcellerated T Cells 59 ALN TTR 59 Insegia 59 metaglidasen 59 subcutaneous formulation 59 Bicifadine 59 dermal patch 59 ThermoDox ® clinical 59 Regado 59 forodesine hydrochloride 59 CTAP# Capsules 59 RECOTHROM ® 59 CORT # 59 GTC recombinant human 59 GVAX ® 59 oral gallium 59 oral probiotic 59 CollaFix ™ 59 ZEVALIN ® 59 novel VDA molecule 59 candidate epratuzumab 59 Fibrillex TM 59 ZymoGenetics intends 59 cartilage regeneration 59 HIV maturation inhibition 59 investigational immunotherapy 59 octreotide implant 59 Transdel TM 59 Entereg R 59 ionotropic glutamate receptor antagonists 59 Onalta 59 MyVax ® 59 JAK inhibitor 59 candidate MyVax 59 refractory chronic lymphocytic 59 intravenous acetaminophen 59 Qutenza TM 59 MAGE A3 ASCI 59 drug eluting coronary stent 59 CMV vaccine 59 candidates Azedra 59 Disease IBD 59 apricitabine ATC 59 MONOVISC 59 candidate XP# 59 novel antifolate currently 59 developing TB4 59 Amplimexon 59 BEMA Granisetron 59 CINTREDEKIN BESUDOTOX 59 Xanafide 59 MEK inhibitor RDEA# 59 OMNARIS HFA 59 volociximab 59 Micromet proprietary BiTE 59 RIGScan 59 Dapagliflozin 59 GALNS 59 replacement PAVR 59 candidate CRLX# 59 BLA submission 59 ZFP Therapeutics 59 OrCel R 59 DEEP AF 59 radiation sensitizer 59 phenylalanine ammonia lyase 59 liposomal formulation 59 UltiMAb 59 NADiA 59 PATHFINDER ® TRACER 59 unique PER.C6 59 forodesine 59 Selective Electrochemical Tumor Ablation 59 Convivia TM 59 MP4 molecule 59 ongoing Phase IIIb 59 Silenor ® doxepin 59 Celator 59 ATL# [001] 59 CINtec R 59 CR# vcMMAE 59 PEG PAL PEGylated recombinant 59 TAXUS Element Paclitaxel Eluting 59 HepaLife 59 #D#C# 59 alvespimycin 59 buccal insulin spray 59 histamine dihydrochloride 59 Amigal TM 59 Levacor TM 59 Linjeta TM 59 Unit Dose Budesonide 59 NV1FGF 59 hand sanitizer patch 59 Hematide ™ 59 Phase 2a clinical trials 59 liprotamase 59 Phase IIb clinical trials 59 Panzem 59 molecular chaperone regulation 59 trastuzumab DM1 T DM1 59 forodesine HCl 59 endovascular stent graft 59 ACIs 59 Zerenex 59 initiated Phase 1b 59 BrachySil ™ 58 SEQureDx ™ 58 cancer immunotherapies 58 Hemopurifier ® 58 Exalgo TM 58 miniaturized implantable 58 OPTTX System 58 inhaled liposomal ciprofloxacin 58 HepaSphere 58 methylnaltrexone bromide 58 Tezampanel 58 T Pred 58 OncoVEX GM CSF 58 BST CarGel R 58 Phase 1a clinical 58 orBec R 58 candidate Puricase 58 Relypsa 58 Phase 1b clinical trials 58 Pralatrexate 58 Rescula 58 polymer platinate 58 Aflibercept 58 IMC #B 58 successfully commercialize Iluvien 58 coronary stent merged 58 otelixizumab 58 EOquin 58 CLIRS trial 58 Veronate R 58 OXIGON 58 autologous cellular immunotherapy 58 next generation URAT1 58 SUPPRELIN LA 58 Annamycin 58 LightTouch ™ 58 diagnostic radiopharmaceutical 58 IV APAP 58 patented Bioral R nanocochleate 58 Ceragenin ™ technology 58 Combidex 58 Myolimus 58 eSVS MESH 58 StaphVAX R 58 mild vasodilator 58 NurOwn 58 TELINTRA R 58 MEND CABG II 58 ViaCyte 58 romazarit 58 POTELLIGENT ® 58 sNDA submission 58 TRISENOX ® 58 TAXUS Element Stent System 58 Traficet EN 58 Novacor LVAS 58 oral taxane 58 sapropterin dihydrochloride Tablets 58 Initiates Enrollment 58 acyclovir Lauriad R 58 HspE7 58 Zingo TM 58 Marqibo 58 mechanical thrombectomy 58 drug eluting stent DES 58 BEMA TM Fentanyl 58 HYVISC R 58 refractory Hodgkin lymphoma 58 Plenaxis TM 58 oritavancin semi 58 CD# CEA 58 Lucanix R 58 Celladon Corporation 58 generation purine nucleoside 58 Plasma Converter TM 58 Phenoptin 58 Augment Bone Graft 58 TRIOLEX ™ 58 Exherin TM 58 Cinryze ™ 58 INT# [002] 58 inhaled formulation 58 candidate ATHX 58 Onconase 58 DNA RNA Medicines 58 oral proteasome inhibitor 58 Zenvia ™ 58 ELND-#/AZD-# 58 miRview mets 58 multicenter Phase II 58 registrational trial 58 anticancer agent 58 ularitide 58 Allovectin 7 58 Eligard R 58 Urokinase 58 DURIN TM 58 MacuSight 58 Retacrit 58 WATCHMAN device 58 ABRAXANE TM 58 BioNumerik 58 Androxal ® 58 budesonide foam 58 dirucotide 58 R sorafenib tablets 58 INCB# [001] 58 pseudobulbar affect PBA 58 NeuroFlo 58 Aviptadil 58 generation calcineurin inhibitor 58 Vicinium TM 58 SUMAVEL 58 Cotara R 58 ADVANCE PD 58 OncoVEX 58 Marqibo TM 58 Captisol enabled 58 include GALNS N 58 vosaroxin 58 CardioFit 58 RhuDex 58 Phase 2b clinical trials 58 AAG geldanamycin analog 58 REG1 Anticoagulation System 58 candidates Azedra TM 58 HCV nucleoside polymerase inhibitors 58 Phase 2b trial 58 ELND# 58 DCVax R 58 generation URAT1 inhibitor 58 DB# [003] 58 LEVADEX ™ 58 diarrhea predominant irritable 58 Phase 2a trial 58 Omthera 58 MelaFind ® 58 LE DT 58 ATPace TM 58 HeartNet 58 therapy Tovaxin 58 Isolagen Process 58 APEX PD 58 intranasal formulation 58 lomitapide 58 AEG# 58 TÎ ² 4 58 Mepact 58 AzaSite TM 58 thymalfasin 58 AQ4N 58 tezampanel NGX# 58 granulated mesalamine 58 Maxy G# 58 anti CD3 monoclonal 58 BiTE antibody 58 elacytarabine 58 APF# 58 drug GAP #B# 58 gastro intestinal inflammation 58 rotary VAD 58 XmAb ™ 58 Premarket Approval PMA 58 oral nucleoside analogue 58 AcryMed Incorporated 58 ThromCat 58 Symphony tCGM 58 Virulizin R 58 anti botulism antibody 58 BRIM2 58 Expression Genetics 58 BLA filing 58 FavId 58 Unigene nasal calcitonin 58 candidate Zemiva TM 58 SomatoKine 58 pivotal bioequivalence 58 EndoTAG TM 58 IMPACS R 58 Icatibant 58 juvenile chondrocytes 58 autologous cell 58 NeoLipid drug 58 HuMax TF 58 Tectin TM 58 OMS# 58 Pradefovir 58 Combo Stent 58 adrenergic regulation 58 immunosuppressive compound 58 Aurora kinase inhibitor 58 phase IIb III 58 histone deacetylase HDAC inhibitor 58 Metastatic Melanoma 58 Phase 2b clinical 58 ELACYT 58 Enable valve 58 DR Cysteamine 58 PolyActive ® 58 LEX System 57 Trifecta valve 57 paclitaxel eluting 57 Cerashield 57 Chimigen TM 57 Ophthotech 57 novel oral anticoagulant 57 Hyphanox 57 developing ostarine selective 57 Bellicum 57 Curaxin 57 SANVAR 57 OMAPRO ™ 57 GLP toxicology studies 57 TKM PLK1 57 entinostat 57 KALBITOR ® 57 mGluR5 negative 57 GRNVAC1 57 blood clot dissolver 57 Micromet BiTE 57 sterile lidocaine patch 57 PREOS 57 Cx# [002] 57 ferumoxytol Injection 57 Crofelemer budesonide foam 57 leading oral taxane 57 Inc. AMEX YMI 57 treat refractory angina 57 OLpur TM H2H 57 Panzem R NCD 57 EcoNail 57 Fortical R 57 human C1 inhibitor 57 ELADUR ™ 57 DETERx ™ 57 stent coating 57 orBec 57 EOquin TM 57 SurgiFrost 57 HydroFix 57 Glufosfamide 57 Cobalamin 57 IMiDs 57 BENLYSTA ® 57 INxin 57 LHRH antagonist 57 PATHFINDER ® 57 Advaxis Phase 57 Acetavance TM 57 fibrin sealant 57 allogeneic cell 57 AE# vaccine 57 Protexia R 57 Sernova 57 oral ridaforolimus 57 Prednisporin TM 57 CardioPass TM 57 Pervasis 57 candidate iSONEP TM 57 MGCD# [001] 57 vaccines oncolytic virus 57 catheter occlusion 57 Urocortin 2 57 PATHFINDER R 57 TURBO Booster 57 2 methoxyestradiol 57 Adnectin 57 Cetrorelix 57 Phase #b/#a trial 57 Cethrin 57 AN# novel 57 Empatic TM 57 mocetinostat MGCD# 57 Completes Patient Enrollment 57 MASCT System 57 intranasal insulin product 57 Solzira TM 57 oral beclomethasone dipropionate 57 Prochymal TM 57 aortic stent grafts 57 ASONEP 57 Triolex 57 lorvotuzumab mertansine 57 rxRNA 57 proprietary intranasal insulin 57 ReN# 57 VISICOL R 57 Fibrin Pad 57 developing ViaCyte SM 57 HYVISC ® treatment 57 NexACT 57 Hemospan R 57 LPM TM 57 arsenic trioxide injection 57 Homspera TM 57 Epanova 57 Vascugel 57 cintredekin besudotox 57 bifurcation stent 57 Initiates Phase II 57 autologous bone marrow 57 kidney urologic 57 DIFICID ™ 57 product Fentanyl TAIFUN 57 talactoferrin 57 IgG1 monoclonal antibody 57 Telik logo TELINTRA 57 TP# CETi 1 57 telomerase therapeutic 57 Pruvel 57 treat lupus renal 57 Veregen TM 57 HepaGam B 57 Daclizumab 57 platforms GVAX 57 Sym# 57 proprietary bioresorbable polymer 57 deforolimus 57 ongoing Phase 1b 57 poly ethylene glycol PEG 57 embolotherapy 57 rhFVIIa 57 Lixivaptan 57 IONSYS TM 57 Solzira ™ 57 inflammatory autoimmune diseases 57 Novacor R 57 TAFA# 57 Etubics 57 Intarcia 57 CD# monoclonal antibody 57 Collategene 57 topical non steroidal 57 TG# [003] 57 tramiprosate Alzhemed TM 57 HepDirect technology 57 Opterone R 57 sulodexide 57 Investigational Device Exemption 57 QTinno TM 57 Phase 2b study 57 zolpidem tartrate sublingual tablet 57 TFAS TM 57 evaluating satraplatin 57 EpiCept NP 1 57 cyclobenzaprine hydrochloride extended 57 OTCBB HXBM developer 57 Celution TM System 57 TNFerade TM 57 Aztreonam 57 DURIN 57 personalized immunotherapy 57 Zavesca r 57 Emezine 57 synthetic retinoid 57 MyoCell TM 57 MYO VAD TM 57 Andara TM OFS 57 Junovan TM 57 biodegradable implant 57 vii Cubist ability 57 TRANSDUR Bupivacaine 57 clinical trials dacetuzumab SGN 57 Tarceva TM 57 Cutanea 57 Orathecin 57 DURECT proprietary 57 Phase III clinical 57 Anticalins R 57 Receives Orphan Drug Designation 57 personalized dendritic 57 RLY# 57 Proteon Therapeutics Inc. 57 lexidronam injection 57 DermaVir Patch 57 Microcutter 57 proven proprietary Acuform 57 PROMUS Element Stent 57 hyaluronidase enzyme 57 maribavir 57 Wafer polifeprosan 57 vaginally administered lidocaine 57 Européenne Mark 57 doxercalciferol 57 HCD# [002] 57 stent DES 57 PSMA ADC 57 pafuramidine maleate 57 Medarex applies 57 TFChem licenses 57 VeraTag 57 tivozanib AV 57 tanespimycin 57 Tβ4 synthetic copy 57 CentriMag 57 MAb therapy 57 systemic anaplastic large 57 AcryMed technologies 57 PD2i Analyzer 57 Neuradiab 57 CDK cyclin dependent 57 refractory angina 57 TRIOLEX TM HE# 57 CryoCor Cardiac Cryoablation System 57 commercialize becocalcidiol patented 57 Prestara TM 57 Neo Bladder Augment 57 GeneICE 57 Celution System 57 proprietary PharmacoSurgery ™ 57 OXi# 57 BiTE R 57 prGCD 57 bazedoxifene conjugated estrogens 57 ProLindac TM 57 European Sepsis Trial 57 pharmacokinetic PK 57 treat GI GVHD 57 delivery polymer matrix 57 Cellegesic 57 MAP# 57 Intermezzo R 57 treat chronic sinusitis 57 Chrysalin r rusalatide acetate 57 oral dual endothelin 57 Vitamin D analogue 57 indications Cytokinetics 57 treat dysmenorrhea 57 AOP Orphan 57 Sangamo ZFP TF 57 hormone agonist 57 tezampanel 57 AVN# [001] 57 Albugon 57 VIAdel ™ technology 57 Ascendra 57 Xcelerant Delivery System 57 RSD# iv 57 Nanobody ® 57 HuMax Wnt 57 Glassia 57 HepaLife TM 57 RenaZorb TM 57 LentiVector 57 Lung Rx 57 therapeutic monoclonal antibodies 56 Clolar ® 56 BAY #-# 56 Surgical Ablation System 56 N acetylgalactosamine 6 56 Endologix Powerlink System 56 HuMax CD4 56 Litx 56 Drug Eluting Stent System 56 R roscovitine 56 SIMPLE Antibody TM 56 Restoraderm R 56 VEGFR2 inhibitor 56 UltiMAb ® 56 CoAxia 56 Tengion Neo Bladder Augment 56 Phase #b/#a 56 Kuvan R 56 tolevamer 56 rALLy trial 56 TriActiv 56 UPLYSO 56 immunotherapeutic agent 56 advanced polymer conjugate 56 anti emetic therapy 56 Urocidin TM 56 elotuzumab 56 commercialize CorMedix drug 56 OsteoSponge ® SC 56 Lauriad 56 vapreotide acetate 56 MAA submission 56 opioid induced bowel dysfunction 56 Orapred ODT 56 oral formulation 56 tafamidis 56 Custom NX 56 REMOXY POSIDUR ELADUR 56 vaccine GRNVAC1